{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:11:53Z","timestamp":1791587513161,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>After the longest time opposing all transfers of embryos by preimplantation genetic testing for aneuploidy (PGT-A) diagnosed as \u201cchromosomal-abnormal,\u201d the field has over recent years slowly been moving toward selective transfers of by PGT-A as \u201cmosaic\u201d diagnosed embryos, but is still rejecting transfers of embryos by PGT-A defined as \u201caneuploid.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Upon review of the literature, we report published cases of euploid pregnancies following transfers of PGT-A as \u201caneuploid\u201d diagnosed embryos and add several additional, ongoing cases at our center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the published cases from our center, we identified seven euploid pregnancies from \u201caneuploid\u201d embryos, four of which preceded the PGT-A industry\u2019s 2016 switch from binary \u201ceuploid\u201d \u2013 \u201caneuploid\u201d reporting to \u201ceuploid,\u201d \u201cmosaic,\u201d and \u201caneuploid\u201d reporting. That\u00a0those four cases post 2016 PGT-A definition\u00a0involving \u201cmosaic\u201d embryos, therefore, cannot be ruled out. Since then, we recently established three additional ongoing pregnancies from transfers of \u201caneuploid\u201d embryos which still await confirmation of euploidy after delivery. A recent fourth pregnancy from the transfer of a trisomy 9 embryo miscarried before a fetal heart. Outside our own center\u2019s experience, the literature revealed only one additional such transfer, involving PGT-A as a \u201cchaotic-aneuploid\u201d diagnosed embryo with six abnormalities, leading to normal euploid delivery. In reviewing the literature, we furthermore demonstrate why current PGT-A reporting that differentiates between \u201cmosaic\u201d and \u201caneuploid\u201d embryos based on relative percentages of euploid and aneuploid DNA in a single trophectoderm biopsy of on average 5-6 cells, is biologically non-sensical.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Basic biological evidence and a clinically still very limited experience with transfers of PGT-A as \u201caneuploid\u201d labeled embryos demonstrate beyond reasonable doubt that at least some \u201caneuploid\u201d embryos can lead to healthy euploid births. Therefore, this observation establishes beyond reasonable doubt that the rejection of all \u201caneuploid\u201d embryos from transfer reduces pregnancy and live birth chances for IVF patients. Whether (and to what possible degree) pregnancy and live birth chances differ between \u201cmosaic\u201d and \u201caneuploid\u201d embryos, remains to be determined. The answer will likely depend on the aneuploidy(ies) of an embryo and to what degree percentages of \u201cmosaicism\u201d in a single, on average 5\/6-cell trophectoderm biopsy can reflect the ploidy-status of a complete embryo.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12958-023-01077-7","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T03:03:35Z","timestamp":1678244615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Previously reported and here added cases demonstrate euploid pregnancies followed by PGT-A as \u201cmosaic\u201d as well as \u201caneuploid\u201d designated embryos"],"prefix":"10.1186","volume":"21","author":[{"given":"Norbert","family":"Gleicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Patrizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyka","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"issue":"81","key":"1077_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molmed.2020.11.009","volume":"27","author":"N Gleicher","year":"2021","unstructured":"Gleicher N, Patrizio P, Brivanlou A. Preimplantation genetic testing for aneuploidy \u2013 a castle built on sand. Trends Mol Med. 2021;27(81):731\u201342.","journal-title":"Trends Mol Med"},{"key":"1077_CR2","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1056\/NEJMsb2101718","volume":"385","author":"S Mastenbroek","year":"2021","unstructured":"Mastenbroek S, de Wert G, Adashi EY. The imperative of responsible innovation in reproductive medicine. N Engl J Med. 2021;385:2096\u2013100.","journal-title":"N Engl J Med"},{"key":"1077_CR3","doi-asserted-by":"crossref","unstructured":"Schattman GL. Preimplantation genetic testing for aneuploidy: It's d\u00e9j\u00e0 vu all over again! Fertil Steril. 2019;112(6):1046\u20137.","DOI":"10.1016\/j.fertnstert.2019.08.102"},{"issue":"3","key":"1077_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41591-022-01712-7","volume":"28","author":"N Gleicher","year":"2022","unstructured":"Gleicher N, Albertini DF, Patrizio P, Orvieto R, Adashi EY. The uncertain science of preimplantation and prenatal genetic testing. Nat Med. 2022;28(3):442\u20134.","journal-title":"Nat Med"},{"issue":"120","key":"1077_CR5","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1093\/humrep\/deac052","volume":"37","author":"N Gleicher","year":"2022","unstructured":"Gleicher N, Barad DH, Patrizio P, Orvieto R. We have reached a dead end for preimplantation genetic testing for aneuploidy. Hum Reprod. 2022;37(120):2730\u20134.","journal-title":"Hum Reprod"},{"key":"1077_CR6","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.fertnstert.2020.11.041","volume":"115","author":"M Viotti","year":"2021","unstructured":"Viotti M, Victor AR, Barnes FL, Zouves CG, Besser AG, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Feril Steril. 2021;115:1212\u201324.","journal-title":"Feril Steril"},{"issue":"6","key":"1077_CR7","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/humrep\/deac063","volume":"37","author":"DH Barad","year":"2022","unstructured":"Barad DH, Albertini DF, Molinari E, Gleicher N. IVF outcomes of embryos with abnormal PGT-A biopsy previously refused transfer: a prospective cohort study. Hum Reprod. 2022;37(6):1194\u2013206.","journal-title":"Hum Reprod"},{"issue":"9","key":"1077_CR8","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/humrep\/deac151","volume":"37","author":"DH Barad","year":"2022","unstructured":"Barad DH, Albertini DF, Gleicher N. In science truth ultimately wins, and PGT-A is no exception. Hum Reprod. 2022;37(9):2216\u20138.","journal-title":"Hum Reprod"},{"issue":"2","key":"1077_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2019.103741","volume":"63","author":"S Munne","year":"2020","unstructured":"Munne S, Spinella F, Grifo J, Zhang J, Parriego Beltran M, et al. Clinical outcomes after the transfer of blastocysts characterized as mosaic by high resolution next generation sequencing \u2013 further insights. Eur J Med Genet. 2020;63(2):103741.","journal-title":"Eur J Med Genet"},{"issue":"12","key":"1077_CR10","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.ajhg.2021.11.002","volume":"108","author":"A Capalbo","year":"2021","unstructured":"Capalbo A, Poli M, Rienzi L, Girardi L, Patassini C, Fabiani M, et al. Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial. Am J Hum Genet. 2021;108(12):2238\u201347.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1077_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.rbmo.2022.03.013","volume":"45","author":"D Leigh","year":"2022","unstructured":"Leigh D, Cram DS, Rechitsky S, Handyside D, Wells S, et al. PGDIS position statement on the transfer of mosaic embryos 2021. Reprod BioMed Online. 2022;45(1):19\u201325.","journal-title":"Reprod BioMed Online"},{"issue":"4","key":"1077_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41556-021-00660-7","volume":"23","author":"M Yang","year":"2021","unstructured":"Yang M, Rito T, Metzger J, Naftaly J, Soman R, Hu J, et al. Depletion of aneuploid cell is human embryos and gastruloids. Nat Cell Biol. 2021;23(4):314\u201321 Author Correction: Nat Cell Biol 2021;23(11):1212.","journal-title":"Nat Cell Biol"},{"issue":"7876","key":"1077_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41586-021-03790-y","volume":"597","author":"THH Coorens","year":"2021","unstructured":"Coorens THH, Moore L, Robinson PS, Sanghvi R, Christopher J, et al. Extensive phlogenies of human development inferred from somatic mutations. Nature. 2021;597(7876):387\u201392.","journal-title":"Nature"},{"issue":"1","key":"1077_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12958-017-0251-8","volume":"15","author":"N Gleicher","year":"2017","unstructured":"Gleicher N, Metzger J, Croft G, Kushnir VA, Albertini DF, Barad DH. A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use. Reprod Biol Endocrinol. 2017;15(1):33.","journal-title":"Reprod Biol Endocrinol"},{"key":"1077_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.fertnstert.2019.07.1346","volume":"112","author":"S Munn\u00e9","year":"2019","unstructured":"Munn\u00e9 S, Kaplan B, Frattarelli JL, Child T, Nakhuda G, et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019;112:1071\u20139.","journal-title":"Fertil Steril"},{"key":"1077_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.07.180","volume":"104","author":"N Gleicher","year":"2015","unstructured":"Gleicher N, Vidali A, Braverman J, Kushnir VA, Albertini DF, Barad DH. Further evidence against use f PGS in poor prognosis patients: report of normal births after transfer of embryos reported as aneuploid (abstract). Fertil Steril. 2015;104:e59.","journal-title":"Fertil Steril"},{"issue":"4","key":"1077_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.xfre.2022.10.003","volume":"3","author":"J Lin","year":"2022","unstructured":"Lin J, Vitek W, Scott EL. Order from chaos: a case report of a healthy live birth from a genetically \u201cchaotic\u201d embryo. F S Reports. 2022;3(4):301\u20134.","journal-title":"F S Reports"},{"issue":"4","key":"1077_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.xfre.2022.11.004","volume":"3","author":"DH Barad","year":"2022","unstructured":"Barad DH. Preimplantation genetic testing for aneuploidies screening is not diagnostic. F S Reports. 2022;3(4):294\u20135.","journal-title":"F S Reports"},{"key":"1077_CR19","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.1038\/ncomms11165","volume":"7","author":"H Bolton","year":"2016","unstructured":"Bolton H, Graham SJL, Van de Aa N, Kumar P, Theunis K, Fernandez Gallardo E, et al. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nat Commun. 2016;7:11165.","journal-title":"Nat Commun"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-023-01077-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T03:06:41Z","timestamp":1678244801000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-023-01077-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1186\/s12958-023-01077-7","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data were obtained already deidentified and the protocol of the study was approved by local Institutional Review Boards (IRBs) in New York (Name: IRB of the Center for Human Reproduction) as well as Israel (Name: IRB of Tel-Aviv University School of Medicine). The methodology of the study was carried out in accordance with all relevant guidelines and regulations in accordance with the Declaration of Helsinki. Because data was received anonymized, there was no possibility to obtain individual consents.U.S. patients had, however, signed individual consents that permitted the use of their medical records for research purposes as long as their identity was not revealed, and their medical records remained confidential. Both conditions were met. The study did not involve patients below the age of 18.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Gleicher and Dr. Barad are listed as co-inventor on several U.S. patents, none in any way related to here presented manuscript. They also received research support, travel funds, and speaker honoraria from several pharmaceutical and medical device companies, though, again, none related to here presented subjects and manuscript. Dr. Gleicher is a shareholder in Fertility Nutraceuticals and receives royalty payments from Fertility Nutraceuticals LLC. Dr. Patrizio reports no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}